Supernus Pharm (SUPN) Posts Mixed Q2 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Nasdaq futures gain as SK Hynix lifts chips ahead of Fed decision, earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil up over 1% as Saudi Arabian refinery attack reignites supply risk concerns
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
Tweet
Share
E-mailGet Alerts SUPN Hot Sheet
Join SI Premium – FREE
Supernus Pharm (NASDAQ: SUPN) reported Q2 EPS of ($5.17), $4.71 worse than the analyst estimate of ($0.46). Revenue for the quarter came in at $750 thousand versus the consensus estimate of $70 thousand.
For earnings history and earnings-related data on Supernus Pharm (SUPN) click here.
For earnings history and earnings-related data on Supernus Pharm (SUPN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Franklin Electric (FELE) Tops Q3 EPS by 8c; offers guidance
- Brinker International (EAT) Tops Q1 EPS by 35c ; Offers Guidance
- Chefs' Warehouse (CHEF) Tops Q3 EPS by 8c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
